Atherosclerosis in hemodialysis patients--the role of microinflammation

Sebastjan Bevc1, Samir Sabic, Radovan Hojs

  • 1Clinic for Internal Medicine, Department of Dialysis, University Medical Center Maribor, Maribor, Slovenia. sebastjanb@yahoo.com

Renal Failure
|November 19, 2008
PubMed

Insights

Cardiovascular disease risk in hemodialysis patients is linked to inflammation. Atherosclerosis in these patients correlates with inflammatory markers like interleukin 2 receptor and VCAM-1, suggesting non-traditional risk factors.

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of death in end-stage renal disease (ESRD) patients.
  • Hemodialysis (HD) patients exhibit a higher risk for coronary heart disease than the general population.
  • Traditional risk factors do not fully explain the elevated CVD risk in HD patients.

Purpose of the Study:

  • To investigate correlations between asymptomatic atherosclerosis and inflammatory markers in HD patients.
  • To assess specific inflammatory markers including hsCRP, IL-6, TNF-alpha, IL-2R, ICAM-1, and VCAM-1.
  • To identify potential non-traditional risk factors for CVD in HD patients.

Main Methods:

  • Ninety-five HD patients (56% male, mean age 60 years) were included.
  • B-mode ultrasonography measured intima-media thickness (IMT) and plaque occurrence in carotid arteries.
  • Serum concentrations of inflammatory markers were determined from blood samples.

Main Results:

  • Mean IMT was 0.83 mm; 84% of patients had plaques.
  • Significant correlations were found between IMT and IL-2R (r=0.269, p<0.022) and VCAM-1 (r=0.290, p<0.014).
  • Multiple linear regression analysis indicated a relationship between IMT and IL-2R (p=0.049). No association was found between inflammatory markers and plaques.

Conclusions:

  • Atherosclerosis in HD patients is associated with specific inflammatory markers.
  • Interleukin 2 receptor (IL-2R) and VCAM-1 are identified as potential nontraditional risk factors for atherosclerosis in this population.
  • Inflammation plays a role in the development of atherosclerosis in hemodialysis patients.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...